Monica Yague-Fernandez
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Monica Yague-Fernandez has a total of 8 co-authors. Here are the top co-authors by number of shared publications:
- Arantzazu Barquín García
Unit of Gynecological, Genitourinary and Skin Tumors, Hospital HM Sanchinarro, Fundación Investigación HM Hospitales, Madrid, Spain
4 shared publications - José Luis Rojo-Álvarez
Universidad Rey Juan Carlos Madrid Spain
4 shared publications - Luis Bote-Curiel
Department of Signal Theory and Communications and Telematic Systems and Computation, Rey Juan Carlos University, Fuenlabrada Campus, Madrid, Spain
4 shared publications - Sergio Muñoz-Romero
Department of Signal Theory and Communications, Telematics, and Computing Systems, Universidad Rey Juan Carlos, Madrid, Spain
3 shared publications - Sergio Ruiz-Llorente
Unit of Gynecological, Genitourinary and Skin Tumors, Hospital HM Sanchinarro, Fundación Investigación HM Hospitales, Madrid, Spain
3 shared publications Jesus Garcia-Donas
Unit of Gynecological, Genitourinary and Skin Tumors, Hospital HM Sanchinarro, Fundación Investigación HM Hospitales, Madrid, Spain
2 shared publications
Latest Publications
- 4 September 2023
- Published by Institute of Electrical and Electronics Engineers (IEEE)
- p. 1160-1164
Predicting Ovarian Cancer with Machine Learning: Integrating Clinical and Genetic Data
Ovarian cancer (OC) is a deadly disease that affects a large number of women worldwide. Machine Learning (ML) models can help in the early detection of this disease, however, the use of these models may be limited by their lack of interpretability and the difficulty to evaluate their performance. In this work, five types of datasets were used, employing clinical features, different types of coding genomic features, and combining both. The use of interpretable ML (IML) models (one linear and one nonlinear model) provided us with better interpretability of the five feature sets. Following this study, nine binary classification models were compared, and the Accuracy, Recall, and Area Under the Curve were analyzed. The results showed that ML models employed the combination of clinical features and genomes with the coding of the position of genes in patients significantly improves the prediction. We demonstrated that the inclusion of different preprocessed patient data and especially through the information provided by IML models, can help clinicians to understand the disease better and make informed treatment decisions.
- 4 September 2023
- Published by Institute of Electrical and Electronics Engineers (IEEE)
- p. 1160-1164
Predicting Ovarian Cancer with Machine Learning: Integrating Clinical and Genetic Data
Ovarian cancer (OC) is a deadly disease that affects a large number of women worldwide. Machine Learning (ML) models can help in the early detection of this disease, however, the use of these models may be limited by their lack of interpretability and the difficulty to evaluate their performance. In this work, five types of datasets were used, employing clinical features, different types of coding genomic features, and combining both. The use of interpretable ML (IML) models (one linear and one nonlinear model) provided us with better interpretability of the five feature sets. Following this study, nine binary classification models were compared, and the Accuracy, Recall, and Area Under the Curve were analyzed. The results showed that ML models employed the combination of clinical features and genomes with the coding of the position of genes in patients significantly improves the prediction. We demonstrated that the inclusion of different preprocessed patient data and especially through the information provided by IML models, can help clinicians to understand the disease better and make informed treatment decisions.
- Open Access
- 20 June 2022
- Published by Elsevier in Expert Systems with Applications
- Vol. 206
Multivariate feature selection and autoencoder embeddings of ovarian cancer clinical and genetic data
- 20 June 2022
- Published by Elsevier in Expert Systems with Applications
- Vol. 206
Open AccessMultivariate feature selection and autoencoder embeddings of ovarian cancer clinical and genetic data
- Open Access
- 13 April 2021
- Published by Institute of Electrical and Electronics Engineers (IEEE) in IEEE Access
- Vol. 9, 58034-58051
Text Analytics and Mixed Feature Extraction in Ovarian Cancer Clinical and Genetic Data
Developments of richer integrative analysis methods for oncological studies are needed for efficiently leveraging the amount of clinical and genetic data available to provide the clinicians with better information. However, analyses of this nature often require mixing data of different types, which are not immediate to address jointly with classical methods. In this work, our aim is to find relationships between clinical and genetic features of different types (metric, categorical, and text) and the ovarian cancer (OC) disease progression. To this end, we first propose a univariate statistical method for text type applying bootstrap resampling to Bag of Words and Latent Dirichlet Allocation in order to include as features the free-text fields of the health recordings. Secondly, we extend bootstrap resampling for metric and categorical feature extraction with Principal Component Analysis (PCA) and Multiple Correspondence Analysis (MCA), respectively. We subsequently formulate a novel and integrative method for jointly considering metric, categorical, and text features. Results obtained in text analysis indicate individual differences in some words between two OC patients groups categorised according to their sensitivity to platinum drugs. These results indicate separability between both groups for text features. Also, regarding the multivariate analysis, clinical data results showed separability patterns for the three methods analysed according to the platinum-sensitivity degree. The use of these analytical tools in our OC cohort has allowed us to demonstrate their strengths by confirming the predictive and prognostic role of widely-known clinical and genetic variables (BRCA status, value of adjuvant therapy and optimal resection, or family history) and demonstrating significant associations in other variables whose role in OC development has been studied to a lesser extent (such as PMS1, GPC3, and SLX4 genes). These results highlight the value of implementing these approaches for the identification of novel biomarkers in the context of OC.
- 13 April 2021
- Published by Institute of Electrical and Electronics Engineers (IEEE) in IEEE Access
- Vol. 9, 58034-58051
Open AccessText Analytics and Mixed Feature Extraction in Ovarian Cancer Clinical and Genetic Data
Developments of richer integrative analysis methods for oncological studies are needed for efficiently leveraging the amount of clinical and genetic data available to provide the clinicians with better information. However, analyses of this nature often require mixing data of different types, which are not immediate to address jointly with classical methods. In this work, our aim is to find relationships between clinical and genetic features of different types (metric, categorical, and text) and the ovarian cancer (OC) disease progression. To this end, we first propose a univariate statistical method for text type applying bootstrap resampling to Bag of Words and Latent Dirichlet Allocation in order to include as features the free-text fields of the health recordings. Secondly, we extend bootstrap resampling for metric and categorical feature extraction with Principal Component Analysis (PCA) and Multiple Correspondence Analysis (MCA), respectively. We subsequently formulate a novel and integrative method for jointly considering metric, categorical, and text features. Results obtained in text analysis indicate individual differences in some words between two OC patients groups categorised according to their sensitivity to platinum drugs. These results indicate separability between both groups for text features. Also, regarding the multivariate analysis, clinical data results showed separability patterns for the three methods analysed according to the platinum-sensitivity degree. The use of these analytical tools in our OC cohort has allowed us to demonstrate their strengths by confirming the predictive and prognostic role of widely-known clinical and genetic variables (BRCA status, value of adjuvant therapy and optimal resection, or family history) and demonstrating significant associations in other variables whose role in OC development has been studied to a lesser extent (such as PMS1, GPC3, and SLX4 genes). These results highlight the value of implementing these approaches for the identification of novel biomarkers in the context of OC.
- Open Access
- 8 February 2021
- Published by Institute of Electrical and Electronics Engineers (IEEE) in IEEE Access
- Vol. 9, 25959-25972
A Resampling Univariate Analysis Approach to Ovarian Cancer From Clinical and Genetic Data
Ovarian cancer (OC) is the second most common gynecological malignancy and the gynecological tumor with the worst prognosis. To try to improve this situation, Data Science technologies could be a useful tool to help clinicians to know more about the disease. In our case, we are interested in exploring OC data to discover relationships between clinical and genetic factors and the disease progression. For it, we propose an analysis framework for simple and univariate statistical descriptions of features of different types, based on bootstrap resampling. Foremost, we define the framework for metric, categorical, and dates variables and determine what are the advantages and disadvantages of using different bootstrap resampling strategies, based on their statistical basis. Then, we use it to perform a univariate analysis over an OC dataset that allows to explore how is the disease progression, having platinum-free interval as indicator, in relation to clinical and genetic features of different types. Also, it provides a first set of variables possibly relevant for survival prediction. Results obtained show that some features have led to individual differences between both platinum resistant (6 months) groups. It can be concluded that this could be an indicator that the database could be discriminatory for the hypotheses studied, though it is convenient to make multivariate analyses to check how relationships among features are influenced.
- 8 February 2021
- Published by Institute of Electrical and Electronics Engineers (IEEE) in IEEE Access
- Vol. 9, 25959-25972
Open AccessA Resampling Univariate Analysis Approach to Ovarian Cancer From Clinical and Genetic Data
Ovarian cancer (OC) is the second most common gynecological malignancy and the gynecological tumor with the worst prognosis. To try to improve this situation, Data Science technologies could be a useful tool to help clinicians to know more about the disease. In our case, we are interested in exploring OC data to discover relationships between clinical and genetic factors and the disease progression. For it, we propose an analysis framework for simple and univariate statistical descriptions of features of different types, based on bootstrap resampling. Foremost, we define the framework for metric, categorical, and dates variables and determine what are the advantages and disadvantages of using different bootstrap resampling strategies, based on their statistical basis. Then, we use it to perform a univariate analysis over an OC dataset that allows to explore how is the disease progression, having platinum-free interval as indicator, in relation to clinical and genetic features of different types. Also, it provides a first set of variables possibly relevant for survival prediction. Results obtained show that some features have led to individual differences between both platinum resistant (6 months) groups. It can be concluded that this could be an indicator that the database could be discriminatory for the hypotheses studied, though it is convenient to make multivariate analyses to check how relationships among features are influenced.